The need for laboratories for cardiac catheterisation and angiography, and pacemaker implantation, is assessed The National Service Framework (NSF) forcoronary heart disease (CHD) states that: “Byinternational standards, the UK has high rates of CHD but low rates of coronary artery revascularisation. This does not appear to be because most other countries are over-using revascularisation but rather there has been under-provision of revascularisation in the UK. Another major difference between the UK and most other developed countries is that people in the UK wait considerably longer for investigation and treatment than people elsewhere.”1 The NSF has been welcomed by the cardiology community as a means to improve the medica
Background—In 2001, 1176 US hospitals were capable of performing primary percutaneous coronary inter...
<p>Background: The indications, complexity and capabilities of cardiovascular magnetic resonan...
Heart failure is appropriately described as an epidemic, with 1–2% of health care expenditure being ...
(CARMAGUE) study (1) surveyed laboratory practice against the then current clinical practice recom-m...
Background: The aim of this survey was to investigate how well heart failure (HF) guidelines for use...
BACKGROUND: Increased use of invasive coronary strategies in patients admitted to hospitals with on-...
The CARdiac MARker Guideline Uptake in Europe (CAMARGUE) program is a multi-country audit of the use...
More than 300 000 procedures are performed in cardiac catheter laboratories in the UK each year. The...
Background: Natriuretic peptides (NP) are well-established markers of heart failure (HF). During the...
The National Service Framework (NSF) for Coronary Heart Disease, published in the UK in 2000, gave t...
Background: The indications, complexity and capabilities of cardiovascular magnetic resonance (CMR)...
More than 300 000 procedures are performed in cardiac catheter laboratories in the UK each year. The...
Natriuretic peptides (NP) are well-established markers of heart failure (HF). During the past 5 year...
BACKGROUND: We undertook an assessment of current use of evidence-based guidelines for the use of ca...
The National Service Framework (NSF) for Coronary Heart Disease (CHD), recently published by the Dep...
Background—In 2001, 1176 US hospitals were capable of performing primary percutaneous coronary inter...
<p>Background: The indications, complexity and capabilities of cardiovascular magnetic resonan...
Heart failure is appropriately described as an epidemic, with 1–2% of health care expenditure being ...
(CARMAGUE) study (1) surveyed laboratory practice against the then current clinical practice recom-m...
Background: The aim of this survey was to investigate how well heart failure (HF) guidelines for use...
BACKGROUND: Increased use of invasive coronary strategies in patients admitted to hospitals with on-...
The CARdiac MARker Guideline Uptake in Europe (CAMARGUE) program is a multi-country audit of the use...
More than 300 000 procedures are performed in cardiac catheter laboratories in the UK each year. The...
Background: Natriuretic peptides (NP) are well-established markers of heart failure (HF). During the...
The National Service Framework (NSF) for Coronary Heart Disease, published in the UK in 2000, gave t...
Background: The indications, complexity and capabilities of cardiovascular magnetic resonance (CMR)...
More than 300 000 procedures are performed in cardiac catheter laboratories in the UK each year. The...
Natriuretic peptides (NP) are well-established markers of heart failure (HF). During the past 5 year...
BACKGROUND: We undertook an assessment of current use of evidence-based guidelines for the use of ca...
The National Service Framework (NSF) for Coronary Heart Disease (CHD), recently published by the Dep...
Background—In 2001, 1176 US hospitals were capable of performing primary percutaneous coronary inter...
<p>Background: The indications, complexity and capabilities of cardiovascular magnetic resonan...
Heart failure is appropriately described as an epidemic, with 1–2% of health care expenditure being ...